• Campbell L, Hollins AJ, Al-Eid A, Newman GR, von Ruhland C, Gumbleton M. 1999. Caveolin-1 expression and caveolae biogenesis during cell transdifferentiation in lung alveolar epithelial primary cultures. Biochem Biophys Res Commun 262: 744751.
  • Cohen AW, Razani B, Schubert W, Williams TM, Wang XB, Iyengar P, Brasaemle DL, Scherer PE, Lisanti MP. 2004. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 53: 12611270.
  • Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293: 24492452.
  • Fehrenbach H. 2001. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2: 3346.
  • Hnasko R, Lisanti MP. 2003. The biology of caveolae: lessons from caveolin knockout mice and implications for human disease. Mol Interv 3: 445464.
  • Hsia CC, Hyde DM, Ochs M, Weibel ER; ATS/ERS Joint Task Force on Quantitative Assessment of Lung Structure. 2010. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. Am J Respir Crit Care Med 181: 394418.
  • Jin Y, Lee SJ, Minshall RD, Choi AM. 2011. Caveolin-1: a critical regulator of lung injury. Am J Physiol Lung Cell Mol Physiol 300: L151L160.
  • Le Saux O, Teeters K, Miyasato S, Choi J, Nakamatsu G, Richardson JA, Starcher B, Davis EC, Tam EK, Jourdan-Le Saux C. 2008. The role of caveolin-1 in pulmonary matrix remodeling and mechanical properties. Am J Physiol Lung Cell Mol Physiol 295: L1007L1017.
  • Mühlfeld C, Rothen-Rutishauser B, Vanhecke D, Blank F, Gehr P, Ochs M. 2007. Visualization and quantitative analysis of nanoparticles in the respiratory tract by transmission electron microscopy. Part Fibre Toxicol 4: 11.
  • Newman GR, Campbell L, von Ruhland C, Jasani B, Gumbleton M. 1999. Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function. Cell Tissue Res 295: 111120.
  • Ochs M. 2006. A brief update on lung stereology. J Microsc 222: 188200.
  • Ochs M. 2010. The closer we look the more we see? Quantitative microscopic analysis of the pulmonary surfactant system. Cell Physiol Biochem 25: 2740.
  • Palade GE, Bruns RR. 1968. Structural modulations of plasmalemmal vesicles. J Cell Biol 37: 633649.
  • Razani B, Engelman JA, Wang XB, Schubert W, Zhang XL, Marks CB, Macaluso F, Russell RG, Li M, Pestell RG, Vizio DD, Hou H, Kneitz B, Lagaud G, Christ GJ, Edelmann W, Lisanti MP. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem 276: 3812138138.
  • Scherer PE, Lewis RY, Volonte D, Engelman JA, Galbiati F, Couet J, Kohtz DS, van Donselaar E, Peters P, Lisanti MP. 1997. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form stable hetero-oligomeric complex in vivo. J Biol Chem 272: 2933729346.
  • Schlörmann W, Steiniger F, Richter F, Kaufmann R, Hause G, Lemke C, Westermann M. 2010. The shape of caveolae is omega-like after glutaraldehyde fixation and cup-like after cryofixation. Histochem Cell Biol 133: 223228.
  • Sterio DC. 1984. The unbiased estimation of number and sizes of arbitrary particles using the disector. J Microsc 134: 127136.
  • Tang Z, Scherer PE, Okamoto T, Song K, Chu C, Kohtz DS, Nishimoto I, Lodish HF, Lisanti MP. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J Biol Chem 271: 22552261.
  • Torday JS, Rohan VK. 2007. The evolutionary continuum from lung development to homeostasis and repair. Am J Physiol Lung Cell Mol Physiol 292: L608L611.
  • Torday J, Rohan V. 2011. Neutral lipid trafficking regulates alveolar type II cell surfactant phospholipid and surfactant protein expression. Exp Lung Res 37: 376386.
  • Tuder RM, Yoshida T, Arap W, Pasqualini R, Petrache I. 2006. State of the art. Cellular and molecular mechanisms of alveolar destruction in emphysema: an evolutionary perspective. Proc Am Thorac Soc 3: 503510.
  • Vedel-Jensen EB, Gundersen HJG. 1993. The rotator. J Microsc 170: 3544.
  • Xisto DG, Farias LL, Ferreira HC, Picanco MR, Amitrano D, Lapa E, Silva JR, Negri EM, Mauad T, Carnielli D, Silva LF, Capelozzi VL, Faffe DS, Zin WA, Rocco PR. 2005. Lung parenchyma remodelling in a murine model of chronic allergic inflammation. Am J Respir Crit Care Med 171: 829837.
  • Wang Y, Maciejewski BS, Drouillard D, Santos M, Hokenson MA, Hawwa RL, Huang Z, Sanchez-Esteban J. 2010. A role for caveolin-1 in mechanotransduction of fetal type II epithelial cells. Am J Physiol Lung Cell Mol Physiol 298: L775L783.
  • Weibel ER. 1972. Morphometric estimation of pulmonary diffusion capacity. V. Comparative morphometry of alveolar lungs. Respir Physiol 14: 2643.
  • Weibel ER. 1979. Stereological methods. Vol. 1: Practical methods for biological morphometry. London: Academic Press.
  • Wirkes A, Jung K, Ochs M, Mühlfeld C. 2010. Allometry of the mammalian intracellular pulmonary surfactant system. J Appl Physiol 109: 16621669.